著者
井上 正幸 傳 秋光 鳴瀧 恭也
出版者
一般社団法人 日本糖尿病学会
雑誌
糖尿病 (ISSN:0021437X)
巻号頁・発行日
vol.37, no.7, pp.499-502, 1994

Using gas chromatographic mass spectrometry, we identified cholesteryl-6 (2, 6-di-tertialy butylphenol-4)-thioether (CT) in the urine of diabetics with hypercholesterolemia who were being treated with oral glibenclamide, 2.5 mg, and probucol, 500 mg/day.<BR>Presumably probucol was hydrolyzed to form 4-mercapto-2, 6-di-tertialy-butylphenol (MBP), the MBP reacted with cholesterol-5 &alpha;, 6 &alpha;-epoxide, oxidized cholesterol, and CT was then formed as a result of dehydration and condensation reactions.<BR>Probucol is expected to be useful in preventing diabetic macroangiopathy and removing oxidized cholesterol from the plasma into the urine.